ClinicalTrials.gg
DrugBiological

Eflapegrastim clinical trials

Also written SPI-2012 and HM10460A.

studies test it
8
open now
2
in phase 3
2
first study started
2009

How each study uses eflapegrastim is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the eflapegrastim studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
9 Sept 2022 · ROLVEDON · BLA 761148 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Eflapegrastim
7
Rolontis®
5

Development codes

SPI-2012
5
HM10460A
3

Studies by the year they started

8 studies that test it; most in 2017 (2)

Studies that test eflapegrastim, by start year
YearStudies
20091
20131
20161
20172
20201
20211
20231

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
2
Phase 3
2
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 1

Spectrum Pharmaceuticals, Inc (6) · Hanmi Pharmaceutical Company Limited (1) · Eunseong Medical Foundation Good GANG-AN HOSPITAL (1)

Often tested with

Tested in the same studies.

Pegfilgrastim (3) · Docetaxel (1) · Cyclophosphamide (1) · Antineoplastic Agents (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test eflapegrastim.

Studies

Open first, then newest update. How each study uses eflapegrastim is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 8

Codes

What other systems call eflapegrastim · ClinicalTrials.gg INT006342

  • MeSH (NLM) C583329eflapegrastimOne source NLM
  • UNII (FDA) UT99UG9QJXEFLAPEGRASTIMConfirmed FDA, NLM, Wikidata
  • RxNorm 2612526One source FDA
  • Wikidata Q30314101eflapegrastimConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C103856EflapegrastimOne source FDA
  • DrugBank DB15001One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.